Literature DB >> 8627834

Outcome analysis of goal directed therapy for impotence.

J P Jarow1, P Nana-Sinkam, M Sabbagh, A Eskew.   

Abstract

PURPOSE: We assessed patient preference, satisfaction and overall outcome of goal directed management of erectile dysfunction.
MATERIALS AND METHODS: The results of goal directed therapy of impotence were assessed by an independent telephone survey of 377 consecutive men who had not received prior therapy and who were followed for a minimum of 2 years.
RESULTS: Patients preferred medical to surgical therapies despite significantly higher satisfaction rates achieved with surgery. Average number of treatment modalities chosen by each patient was 2 (range 0 to 5). Ultimately, only 40% of the patients achieved a long-term satisfactory result with goal directed therapy. The remainder were not satisfied with the last treatment but chose no further therapy, were lost to followup or refused therapy from the outset.
CONCLUSIONS: Our results clearly demonstrate a patient preference for the least invasive forms of therapy. Patients avoid significantly more effective but also more invasive treatment options despite unsatisfactory results with less invasive methods. Future research efforts should be concentrated on the development of new medical therapies to enhance overall patient satisfaction.

Entities:  

Mesh:

Year:  1996        PMID: 8627834

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  The role of penile prosthetic surgery in the modern management of erectile dysfunction.

Authors:  S Jain; A Bhojwani; T R Terry
Journal:  Postgrad Med J       Date:  2000-01       Impact factor: 2.401

Review 2.  Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members.

Authors:  H L Tan
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

3.  The cost to the United Kingdom National Health Service of managing erectile dysfunction: the impact of sildenafil and prescribing restrictions.

Authors:  Edward C F Wilson; Emma S McKeen; Paul A Scuffham; Martin C J Brown; Kevan Wylie; Geoff Hackett
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

4.  Nonpharmacologic treatment of erectile dysfunction.

Authors:  Drogo K Montague
Journal:  Rev Urol       Date:  2002

5.  Advances in the Management of Post-Radical Prostatectomy Erectile Dysfunction: Treatment Strategies When PDE-5 Inhibitors Don't Work.

Authors:  Bruce R Kava
Journal:  Rev Urol       Date:  2005

Review 6.  Sildenafil: a review of its use in erectile dysfunction.

Authors:  H D Langtry; A Markham
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

7.  The Prostate Cancer Rehabilitation Clinic: a biopsychosocial clinic for sexual dysfunction after radical prostatectomy.

Authors:  A Matthew; N Lutzky-Cohen; L Jamnicky; K Currie; A Gentile; D Santa Mina; N Fleshner; A Finelli; R Hamilton; G Kulkarni; M Jewett; A Zlotta; J Trachtenberg; Z Yang; D Elterman
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

8.  The effect of sildenafil citrate and pentoxifylline combined treatment in the management of erectile dysfunction.

Authors:  Ozdem Levent Ozdal; Cuneyt Ozden; Serkan Gokkaya; Guvenc Urgancioglu; Binhan Kagan Aktas; Ali Memis
Journal:  Int Urol Nephrol       Date:  2007-09-01       Impact factor: 2.370

9.  Trazodone in methandone induced erectile dysfunction.

Authors:  Faezeh Tatari; Vahid Farnia; Reza Faghih Nasiri; Farid Najafi
Journal:  Iran J Psychiatry       Date:  2010

Review 10.  Management of erectile dysfunction following radical prostatectomy.

Authors:  C D Zippe; R Raina; M Thukral; M M Lakin; E A Klein; A Agarwal
Journal:  Curr Urol Rep       Date:  2001-12       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.